https://www.biotechtoinvest.com/research daily 0.75 2022-07-21 https://www.biotechtoinvest.com/research/2022/7/21/update-on-possible-alternative-targets-of-anavex2-73 monthly 0.5 2022-07-21 https://www.biotechtoinvest.com/research/2022/5/15/the-answer-was-here-all-the-time-why-anavex2-73-can-stop-alzheimers-disease monthly 0.5 2022-06-15 https://images.squarespace-cdn.com/content/v1/5c28109f7c93271f5ed199f3/2eeeb075-62c2-4d54-af55-74e646ca0684/FKBP12-273-fitness-small.gif Research - The Answer Was Here All the Time: Why Anavex2-73 Can Stop Alzheimer’s Disease - Make it stand out Figure 2. Possible binding mode of Anavex2-73 to the active site of FKBP12. https://images.squarespace-cdn.com/content/v1/5c28109f7c93271f5ed199f3/e9321820-f647-4946-8f49-cfcbf4e3adf3/anavex273-rapa360.gif Research - The Answer Was Here All the Time: Why Anavex2-73 Can Stop Alzheimer’s Disease - Make it stand out Figure 3. Comparison of possible binding modes of Anavex2-73 to that of rapamycin https://images.squarespace-cdn.com/content/v1/5c28109f7c93271f5ed199f3/29129850-39a3-4130-90bc-f163f3d1025c/anavex273-pep-comp.png Research - The Answer Was Here All the Time: Why Anavex2-73 Can Stop Alzheimer’s Disease - Make it stand out Figure 1. Molecular structures of Anavex2-73 and Phe-Pro dipeptide. Anavex2-73 is presumably a racemic mixture of two enantiomers. https://www.biotechtoinvest.com/research/2022/1/6/model-portfolio-initiated-on-162022 monthly 0.5 2022-01-06 https://www.biotechtoinvest.com/research/2021/3/23/other-niche-players-in-ad-drug-development monthly 0.5 2021-03-23 https://www.biotechtoinvest.com/research/2020/9/15/all-roads-lead-to-rome-compounds-from-avxl-and-sava-likely-target-the-same-sets-of-molecules monthly 0.5 2020-09-15 https://images.squarespace-cdn.com/content/v1/5c28109f7c93271f5ed199f3/1600181921155-WWFGWWVF2QEJ3QPAZ6SJ/sava-avxl-com-2.jpg Research - All roads lead to Rome: compounds from AVXL and SAVA likely target the same sets of molecules Figure 2. The Shared structure of the three compounds. The tertiary amine (6-member ring) and 5-member ring structures bind to sigma-1 receptor. https://images.squarespace-cdn.com/content/v1/5c28109f7c93271f5ed199f3/1600181176602-WGMW6A76R09A42FYGMJ6/sava-avxl.jpg Research - All roads lead to Rome: compounds from AVXL and SAVA likely target the same sets of molecules Figure 1: Structural Comparison of Leading Compounds. https://www.biotechtoinvest.com/research/2020/1/11/nktr-358-an-undervalued-asset-potentially-worth-more-than-bempeg monthly 0.5 2020-01-12 https://www.biotechtoinvest.com/research/2019/12/27/update-on-cassava-sciences-formerly-pain-therapeutics monthly 0.5 2019-12-28 https://www.biotechtoinvest.com/research/category/Parkingson%27s+Disease monthly 0.5 https://www.biotechtoinvest.com/research/category/model+portfolio monthly 0.5 https://www.biotechtoinvest.com/research/category/Alzheimer%27s+Disease monthly 0.5 https://www.biotechtoinvest.com/research/category/immunotherapy monthly 0.5 https://www.biotechtoinvest.com/research/tag/%24NKTR monthly 0.5 https://www.biotechtoinvest.com/research/tag/Parkinson%27s monthly 0.5 https://www.biotechtoinvest.com/research/tag/%24INMB monthly 0.5 https://www.biotechtoinvest.com/research/tag/Eli+Lilly monthly 0.5 https://www.biotechtoinvest.com/research/tag/ISRIB monthly 0.5 https://www.biotechtoinvest.com/research/tag/CRTX monthly 0.5 https://www.biotechtoinvest.com/research/tag/Sigma-1+receptor monthly 0.5 https://www.biotechtoinvest.com/research/tag/Parkinson monthly 0.5 https://www.biotechtoinvest.com/research/tag/PTI-125 monthly 0.5 https://www.biotechtoinvest.com/research/tag/Anavex monthly 0.5 https://www.biotechtoinvest.com/research/tag/Rett monthly 0.5 https://www.biotechtoinvest.com/research/tag/%24AVXL monthly 0.5 https://www.biotechtoinvest.com/research/tag/AVXL monthly 0.5 https://www.biotechtoinvest.com/research/tag/BEMPEG monthly 0.5 https://www.biotechtoinvest.com/research/tag/LLY monthly 0.5 https://www.biotechtoinvest.com/research/tag/INMB monthly 0.5 https://www.biotechtoinvest.com/research/tag/NEKTAR monthly 0.5 https://www.biotechtoinvest.com/research/tag/NKTR-358 monthly 0.5 https://www.biotechtoinvest.com/research/tag/%24BGNE monthly 0.5 https://www.biotechtoinvest.com/research/tag/SAVA monthly 0.5 https://www.biotechtoinvest.com/research/tag/Alzheimer%27s monthly 0.5 https://www.biotechtoinvest.com/research/tag/Cassava monthly 0.5 https://www.biotechtoinvest.com/research/tag/BIIB monthly 0.5 https://www.biotechtoinvest.com/our-next-topic daily 0.75 2019-01-28 https://www.biotechtoinvest.com/model-portfolio daily 0.75 2019-01-21 https://www.biotechtoinvest.com/about daily 0.75 2019-01-23 https://www.biotechtoinvest.com/contact daily 0.75 2022-05-17 https://www.biotechtoinvest.com/disclaimer daily 0.75 2019-01-25 https://www.biotechtoinvest.com/home daily 1.0 2022-05-17 https://images.squarespace-cdn.com/content/v1/573a04372fe131630fd25157/1469729752911-UFETSG39XPIFRSHOM0XH/hero_pattern.png JWZ Consulting Inc https://www.biotechtoinvest.com/services daily 0.75 2019-01-21 https://www.biotechtoinvest.com/clients-harris daily 0.75 2025-05-08